⚠ Evidence warning: Clinical trials or other evidence do not support the claim that myrrh is a working treatment for schistosomiasis and fascioliasis, or its wound and arthritis uses. This page keeps it as a report of what people, websites or other media say.

Myrrh — Benefits Deep Dive

Benefits — scientific infographic poster

Myrrh is the aromatic oleo-gum resin harvested from small thorny Commiphora myrrha trees native to the arid Horn of Africa (Somalia, Ethiopia, Eritrea, Sudan) and the southern Arabian Peninsula (Yemen, Oman). It is best known to Western readers as one of the three gifts of the Magi to the infant Jesus alongside frankincense and gold, but its medicinal use long predates the Nativity — Egyptian embalmers were packing body cavities with myrrh to prevent putrefaction by 2700 BCE, Roman field surgeons carried it for battlefield wounds, and the Ebers Papyrus (c. 1550 BCE) lists it in dozens of formulations. Modern phytochemistry has identified the primary actives as sesquiterpenes (curzerene, furanoeudesma-1,3-diene, lindestrene) and resinous commiphoric acids that disrupt bacterial membranes, inhibit cyclooxygenase-2 (COX-2), and bind opioid receptors. An Egyptian drug made from myrrh resin and volatile oils (Commiphora molmol) has been produced and marketed for schistosomiasis since 2001, by accounts with Egyptian Ministry of Health approval, and was also studied in fascioliasis — a rare modern instance of a traditional herbal remedy becoming a marketed drug, though later randomized trials found low cure rates (details below). Four benefit pages below explore the main uses studied today.

Deep-Dive Articles

🩹

Wound Healing

The oldest documented use — Egyptian embalming (2700 BCE onward), Roman legionary field kits, the Ebers Papyrus wound recipes, and Crusader-era European wound salves. Reported topical use on burn, diabetic, and surgical wounds, with the studies found so far done in rats; the sesquiterpene + commiphoric acid membrane-disruption mechanism; astringent tannin-like protein cross-linking that mechanically seals oozing tissue; and the Egyptian myrrh-derived drug — the rare modern crossover from folk remedy to marketed drug.

Read the deep dive →
🦷

Oral Health

Often called the best-supported clinical application: a 2026 meta-analysis of 8 randomized trials found a small significant reduction in plaque, while effects on gum inflammation and healing were not significant. The German Commission E approval for oral and pharyngeal mucosal inflammation, gingivitis use, modern myrrh-containing commercial mouthwashes, traditional miswak/tooth-powder use, and the dual antimicrobial + astringent mechanism against Streptococcus mutans, Porphyromonas gingivalis, and the dental-plaque biofilm.

Read the deep dive →
🔥

Anti-Inflammatory

Sesquiterpenes and commiphoric acids inhibit cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), and the NF-kappa-B transcription pathway, parallel mechanisms to nonsteroidal anti-inflammatory drug (NSAID) and corticosteroid drugs but more diffuse. Traditional use in osteoarthritis and rheumatoid arthritis, the comparison to Boswellia (frankincense) as a structurally similar resin with overlapping but distinct anti-inflammatory profile, and the synergy when the two ancient resins are co-administered.

Read the deep dive →
🪱

Antimicrobial & Parasitic

The Egyptian myrrh-derived drug for schistosomiasis (Sheir 2001), the subsequent debate over efficacy, the parallel use in fascioliasis (liver fluke; Massoud 2001), antibacterial spectrum against S. aureus (including methicillin-resistant Staphylococcus aureus, MRSA), Gram-negative rods, and the traditional African and Arabian use as an anthelmintic for intestinal worms.

Read the deep dive →

Back to Table of Contents

Table of Contents

  1. Deep-Dive Articles
  2. Why Myrrh Produces Effects Across So Many Systems
  3. Myrrh in Ulcerative Colitis
  4. Myrrh for Everyday Pain in a Volunteer Study
  5. Research Papers: Wound Healing
  6. Research Papers: Oral Health
  7. Research Papers: Anti-Inflammatory
  8. Research Papers: Antimicrobial & Parasitic
  9. Research Papers: Cross-Cutting (Chemistry, Safety, Synergy)
  10. External Authoritative Resources
  11. Connections
  12. Featured Videos

Why Myrrh Produces Effects Across So Many Systems

Most modern pharmaceuticals act on a single molecular target — a receptor, a transporter, an enzyme. Myrrh, like most plant resins, is a chemical orchestra of dozens to hundreds of co-occurring compounds, and its clinical effects emerge from the simultaneous action of four overlapping mechanism classes. Each class maps to a distinct subset of traditional and modern uses.

  1. Sesquiterpene + commiphoric acid membrane disruption — the lipophilic sesquiterpenes (curzerene, furanoeudesma-1,3-diene, lindestrene, furanodiene) and the resinous commiphoric acids integrate into the phospholipid bilayer of bacterial and fungal cell membranes, increasing permeability and dissipating the proton motive force. This is the unifying mechanism behind the broad antimicrobial activity against Staphylococcus aureus (including methicillin-resistant Staphylococcus aureus), oral pathogens like Streptococcus mutans and Porphyromonas gingivalis, Helicobacter pylori, and parasitic worms.
  2. Cyclooxygenase-2, 5-LOX, and NF-kappa-B inhibition — the same sesquiterpenes and commiphoric acids inhibit the cyclooxygenase-2 and 5-lipoxygenase enzymes that produce pro-inflammatory prostaglandins and leukotrienes, and they suppress the NF-kappa-B transcription pathway that drives chronic inflammatory gene expression. This is the mechanism behind myrrh's traditional use in osteoarthritis, rheumatoid arthritis, and the gingival-tissue protective effect that complements its antimicrobial action in oral health applications.
  3. Astringent protein cross-linking — the resinous fraction of myrrh produces a classic astringent effect: it cross-links surface proteins on mucosal and wound tissue, contracting and mechanically sealing tissues that are bleeding, weeping, or inflamed. This is why myrrh has been used continuously since antiquity for battlefield wound treatment and for bleeding gums in gingivitis — the effect is partly antimicrobial and partly mechanical contraction of inflamed mucosa.
  4. Mu-opioid receptor agonism — two furanosesquiterpenes isolated from myrrh (furanoeudesma-1,3-diene and curzerene) bind directly to mu-opioid receptors and produce dose-dependent analgesia in animal models. This was demonstrated in a 1996 Nature paper by Dolara and colleagues and explains why myrrh has been used for pain management across virtually every traditional medical system since antiquity — it is, mechanistically, a weak opioid agonist. It is not unique in this: a 2017 paper counts about 210 plant species from 79 families with painkilling activity acting through opioid receptors.

The anti-inflammatory and painkilling evidence behind these mechanisms comes largely from animals. In a 2011 mouse study, an ethanol extract of myrrh reduced paw swelling and pain writhing, but "All test samples showed no significant analgesic activity on the hot plate pain threshold in mice."

The therapeutic complication is that the same orchestra of mechanisms that produces beneficial effects also produces a non-trivial safety profile. Myrrh is described as a uterine stimulant and herbal references list pregnancy as a contraindication; a 2023 review reports that "women that applied substantial quantity of myrrh while pregnant had miscarriages." On blood thinners, the one documented warfarin case report points the other way from what herbal references usually say: it describes myrrh weakening warfarin's anticoagulant effect (Al Faraj 2005), and in a 2025 study in liver cancer cells a boiled myrrh extract raised the drug-clearing enzyme CYP2C9 more than 3-fold, with the authors warning of herb-drug interactions. Herbal references also describe myrrh adding to the effect of anticoagulant and antiplatelet medications (warfarin, heparin, aspirin, clopidogrel, non-vitamin K oral anticoagulants) through platelet-inhibitory effects, and list stopping it two weeks before surgery. It can lower blood glucose, potentiating insulin and oral hypoglycemics, and it may suppress thyroid hormone production. These effects matter most for people who are pregnant or who take anticoagulant, diabetes or thyroid medicines. The Egyptian myrrh-derived drug, marketed since 2001, has been described as a standardized preparation with defined dosing and monitoring for one indication (schistosomiasis), handled like a conventional drug; the 2001 fascioliasis study gives its formula as 8 parts resin and 3.5 parts volatile oils.

Later trials of that drug reported far lower cure rates than the first study, which had no comparison group and reported 91.7% in 204 patients (Sheir 2001). In two randomized comparisons in Egypt, the myrrh drug cured about 9-16% of infected people and praziquantel about 63-80% (Botros 2005; Barakat 2005). Of 34 people still infected after two myrrh treatments, 32 stopped passing eggs after praziquantel. A multicentre study in mice and hamsters found modest, trivial or no worm reduction with the drug and no activity with crude myrrh extract (Botros 2004). In the fascioliasis work, the human study had 7 patients (Massoud 2001), and a later study in sheep found flukes only 6% fewer than in untreated animals, concluding that "at least some batches" have "little, if any, value" (Botros 2009).

Back to Table of Contents

Myrrh in Ulcerative Colitis

A 12-month double-blind trial of 96 people with ulcerative colitis in remission compared a preparation of myrrh, chamomile and coffee charcoal with the standard drug mesalazine. Relapse came in 53% on the herbal preparation and 45% on mesalazine (P = 0.540), and the preparation was well tolerated. The authors call this "first evidence" for a possible non-inferior effect that needs further study. The preparation is a combination, so the result cannot be credited to myrrh alone.

Back to Table of Contents

Myrrh for Everyday Pain in a Volunteer Study

A pilot study of 184 volunteers (95 women, 89 men) with headache, fever-related pain, joint pain, muscle aches, lower back pain or menstrual cramps gave a commercial myrrh extract at 200 or 400 mg a day, or placebo, for 20 days. Pain relief was scored against each volunteer's own past experience of prescribed painkillers. Men reported relief at 400 mg for almost all of these pains, and women reported relief of lower back pain and fever-related pain at 200 mg. It is a pilot study with subjective scores.

Back to Table of Contents

Research Papers: Wound Healing

  1. Haffor AS (2010). Effect of myrrh (Commiphora molmol) on leukocyte levels before and during healing from gastric ulcer or skin injury. Journal of Immunotoxicology 7(1):68-75. Study in rats. — PubMed PMID: 19995243
  2. Galehdari H, Negahdari S, Kesmati M, Rezaie A, Shariati G (2016). Effect of the herbal mixture composed of Aloe Vera, Henna, Adiantum capillus-veneris, and Myrrha on wound healing in streptozotocin-induced diabetic rats. BMC Complementary and Alternative Medicine 16(1):386. Four-herb ointment in rats. — PubMed PMID: 27716154
  3. Egyptian embalming and antiseptic use of myrrh resin (historical-pharmacological reviews) — PubMed: Egyptian embalming myrrh
  4. Rahman MM, Garvey M, Piddock LJ, Gibbons S (2008). Antibacterial terpenes from the oleo-resin of Commiphora molmol (Engl.). Phytotherapy Research 22(10):1356-1360. Laboratory study. — PubMed PMID: 18570217
  5. Astringent and hemostatic action of myrrh resin in topical wound application — PubMed: Astringent wound action
  6. Su S, Wang T, Duan JA, et al. (2011). Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. Journal of Ethnopharmacology 134(2):251-258. Study in mice. — PubMed PMID: 21167270
  7. Furanoeudesma-1,3-diene and curzerene from myrrh — PubMed: Furanoeudesma sesquiterpenes
  8. Diabetic ulcer healing and herbal topical agents including myrrh — PubMed: Diabetic ulcer myrrh
  9. Burn wound treatment with myrrh-based topical preparations — PubMed: Burn wound treatment
  10. Barakat R, Elmorshedy H, Fenwick A (2005). Efficacy of myrrh in the treatment of human Schistosomiasis mansoni. American Journal of Tropical Medicine and Hygiene 73(2):365-367. — PubMed PMID: 16103605

Back to Table of Contents

Research Papers: Oral Health

  1. Alnakhli RA, Alqalaleef SS, Alesawi JM, et al. (2026). Myrrh in the Management of Periodontal Disease and Gingival Healing: A Systematic Review and Meta-Analysis. Journal of International Society of Preventive & Community Dentistry 16(1):1-19. — PubMed PMID: 42004991
  2. Tipton DA, Lyle B, Babich H, Dabbous MKh (2003). In vitro cytotoxic and anti-inflammatory effects of myrrh oil on human gingival fibroblasts and epithelial cells. Toxicology in Vitro 17(3):301-310. Cell study. — PubMed PMID: 12781209
  3. German Commission E monograph: Myrrh tincture for oral and pharyngeal mucosal inflammation — PubMed: Commission E myrrh
  4. Myrrh-containing commercial mouthwash efficacy in chronic gingivitis — PubMed: Mouthwash gingivitis trial
  5. Anti-microbial activity of myrrh against Porphyromonas gingivalis and periodontal pathogens — PubMed: P. gingivalis activity
  6. Myrrh extract inhibition of Streptococcus mutans and dental caries — PubMed: S. mutans inhibition
  7. Traditional miswak chewing-stick + myrrh dentifrice formulations — PubMed: Miswak + myrrh
  8. Aphthous ulcer (canker sore) treatment with myrrh tincture — PubMed: Aphthous ulcer treatment
  9. Myrrh as endodontic intracanal medicament against Enterococcus faecalis — PubMed: Endodontic medicament
  10. Astringent action of myrrh resin on inflamed gingival mucosa — PubMed: Astringent gingival action

Back to Table of Contents

Research Papers: Anti-Inflammatory

  1. Su S, Wang T, Duan JA, et al. (2011). Anti-inflammatory and analgesic activity of different extracts of Commiphora myrrha. Journal of Ethnopharmacology 134(2):251-258. Study in mice. — PubMed PMID: 21167270
  2. Dolara P, Luceri C, Ghelardini C, et al. (1996). Analgesic effects of myrrh. Nature 379(6560):29. Animal study. — PubMed PMID: 8538737
  3. Germano A, Occhipinti A, Barbero F, Maffei ME (2017). A Pilot Study on Bioactive Constituents and Analgesic Effects of MyrLiq®, a Commiphora myrrha Extract with a High Furanodiene Content. BioMed Research International 2017:3804356. — PubMed PMID: 28626756
  4. Langhorst J, Varnhagen I, Schneider SB, et al. (2013). Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis--a double-blind, double-dummy study. Alimentary Pharmacology & Therapeutics 38(5):490-500. — PubMed PMID: 23826890
  5. Sesquiterpene inhibition of COX-2 and 5-LOX in myrrh extracts — PubMed: COX-2 / 5-LOX inhibition
  6. NF-kappa-B pathway suppression by myrrh and frankincense sesquiterpenes — PubMed: NF-kappa-B suppression
  7. Comparative anti-inflammatory effect of myrrh vs Boswellia — PubMed: Myrrh vs Boswellia
  8. Myrrh + frankincense combination synergy in inflammation models — PubMed: Myrrh + frankincense synergy
  9. Osteoarthritis traditional use of myrrh-frankincense compound preparations — PubMed: OA traditional use
  10. Rheumatoid arthritis and herbal resin therapy — PubMed: RA resin therapy
  11. Commiphoric acids and their COX-inhibitory action — PubMed: Commiphoric acids COX
  12. Furanodiene and methoxyfuranoguaia-9-ene-8-one mu-opioid receptor binding — PubMed: Mu-opioid binding

Back to Table of Contents

Research Papers: Antimicrobial & Parasitic

  1. Sheir Z, Nasr AA, Massoud A, et al. (2001). A safe, effective, herbal antischistosomal therapy derived from myrrh. American Journal of Tropical Medicine and Hygiene 65(6):700-704. — PubMed PMID: 11791960
  2. Massoud A, El Sisi S, Salama O, Massoud A (2001). Preliminary study of therapeutic efficacy of a new fasciolicidal drug derived from Commiphora molmol (myrrh). American Journal of Tropical Medicine and Hygiene 65(2):96-99. Seven patients. — PubMed PMID: 11508399
  3. Botros S, Sayed H, El-Dusoki H, et al. (2005). Efficacy of mirazid in comparison with praziquantel in Egyptian Schistosoma mansoni-infected school children and households. American Journal of Tropical Medicine and Hygiene 72(2):119-123. — PubMed PMID: 15741544
  4. Botros S, William S, Ebeid F, et al. (2004). Lack of evidence for an antischistosomal activity of myrrh in experimental animals. American Journal of Tropical Medicine and Hygiene 71(2):206-210. Study in mice and hamsters. — PubMed PMID: 15306712
  5. Botros SS, El-Lakkany NM, Badawy AA, et al. (2009). Mirazid shows insignificant activity against ovine fascioliasis. Annals of Tropical Medicine and Parasitology 103(7):605-616. Study in sheep. — PubMed PMID: 19825282
  6. Antibacterial activity of myrrh against methicillin-resistant Staphylococcus aureus (MRSA) — PubMed: Myrrh against MRSA
  7. de Rapper S, Van Vuuren SF, Kamatou GP, Viljoen AM, Dagne E (2012). The additive and synergistic antimicrobial effects of select frankincense and myrrh oils--a combination from the pharaonic pharmacopoeia. Letters in Applied Microbiology 54(4):352-358. Laboratory study. — PubMed PMID: 22288378
  8. Traditional Arabian and African anthelmintic use of myrrh — PubMed: Traditional anthelmintic use
  9. Mahboubi M, Kashani LM (2016). The anti-dermatophyte activity of Commiphora molmol. Pharmaceutical Biology 54(4):720-725. Laboratory study. — PubMed PMID: 26427766
  10. Anti-Helicobacter pylori activity of myrrh extracts — PubMed: H. pylori activity
  11. Activity against intestinal protozoa (Giardia, Entamoeba) — PubMed: Anti-protozoal
  12. Biofilm inhibition by myrrh sesquiterpenes — PubMed: Biofilm inhibition

Back to Table of Contents

Research Papers: Cross-Cutting (Chemistry, Safety, Synergy)

  1. Hanus LO, Rezanka T, Dembitsky VM, Moussaieff A (2005). Myrrh--Commiphora chemistry. Biomedical Papers 149(1):3-27. — PubMed PMID: 16170385
  2. Shen T, Li GH, Wang XN, Lou HX (2012). The genus Commiphora: a review of its traditional uses, phytochemistry and pharmacology. Journal of Ethnopharmacology 142(2):319-330. — PubMed PMID: 22626923
  3. Nomicos EY (2007). Myrrh: medical marvel or myth of the Magi? Holistic Nursing Practice 21(6):308-323. — PubMed PMID: 17978635
  4. Tonkal AM, Morsy TA (2008). An update review on Commiphora molmol and related species. Journal of the Egyptian Society of Parasitology 38(3):763-796. — PubMed PMID: 19209761
  5. Batiha GE, Wasef L, Teibo JO, et al. (2023). Commiphora myrrh: a phytochemical and pharmacological update. Naunyn-Schmiedeberg's Archives of Pharmacology 396(3):405-420. — PubMed PMID: 36399185
  6. Uterine stimulant action of myrrh and pregnancy contraindication — PubMed: Pregnancy contraindication
  7. Al Faraj S (2005). Antagonism of the anticoagulant effect of warfarin caused by the use of Commiphora molmol as a herbal medication: a case report. Annals of Tropical Medicine and Parasitology 99(2):219-220. — PubMed PMID: 15814041
  8. Alsharidah A, Alehaideb Z, Alghamdi SS, et al. (2025). Commiphora myrrha resin extract-modulated cytochrome P-450 2C9 enzyme expression in cultured Hep G2 cells is associated with resin extract-derived metabolites binding to Pregnane X receptor. BMC Complementary Medicine and Therapies 25(1):247. Cell study. — PubMed PMID: 40634953
  9. Myrrh and anticoagulant drug interactions (platelet inhibition) — PubMed: Anticoagulant interaction
  10. Hypoglycemic effect of myrrh and diabetes drug interaction — PubMed: Hypoglycemic effect
  11. Thyroid hormone suppression by myrrh — PubMed: Thyroid effect
  12. Allergic contact dermatitis from myrrh essential oil — PubMed: Contact dermatitis
  13. Standardization and quality control of myrrh oleoresin preparations — PubMed: Standardization

Back to Table of Contents

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents